“The Data Security Monitoring Council decided that there is no reason to end the international trial after reviewing the available data on the drug,” Ghebrejsus said.
As we reported before, American scientists have concluded that the anti-malarial hydroxychloroquine used in the treatment of Covid-19 increased the risk of death among patients.
"Patients who were taken to a hospital with Covid-19 and were treated with antimalarial hydroxychloroquine were at a higher risk of death than those who did not take it," the study said.
On June 3, the World Health Organization (WHO) claimed it saw a gradual stabilization of the coronavirus situation in some countries. Ukraine was one of them.